Select Page

Excelsior Equities Initiates Coverage of TerrAscend (TSND.TO/TSNDF)

by | Sep 26, 2023 | News

Mike Regan, Director of Research at Excelsior Equities, has published an initiation report on TerrAscend (TSX: TSDN.TO, C$2.76 / OTC: TSNDF, US$2.03), “Institutional Quality US Cannabis on TSX; Pricing & Adult Use Legislation Catalysts” with a BUY rating and a C$3.50 / US$2.65 2024 price target.

The report is available to institutional investor clients of Excelsior Equities. To request access to the report, submit a request below.